You have 9 free searches left this month | for more free features.

Roll-over Protocol

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumors Trial in Worldwide (Everolimus, Sandostatin LAR Depot)

Completed
  • Neoplasms
  • Little Rock, Arkansas
  • +23 more
May 17, 2021

Cancer Trial (Osimertinib)

Not yet recruiting
  • Cancer
  • (no location specified)
Nov 17, 2022

GIST and CML Trial in Worldwide (AMN107)

Active, not recruiting
  • GIST and CML
  • Albany, New York
  • +32 more
Oct 4, 2022

Ascites, Peritoneal Carcinomatosis, Peritoneum Tumor Trial in Chandigarh (Standard Paracentesis, Roll Over Paracentesis)

Terminated
  • Ascites
  • +3 more
  • Standard Paracentesis
  • Roll Over Paracentesis
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research
Mar 2, 2022

GIST and CML Trial in Worldwide (imatinib mesylate)

Active, not recruiting
  • GIST and CML
  • imatinib mesylate
  • Los Angeles, California
  • +28 more
Apr 25, 2022

Human Immunodeficiency Virus Type 1 Trial in Worldwide (Rilpivirine)

Recruiting
  • Human Immunodeficiency Virus Type 1
  • Brescia, Italy
  • +13 more
Jan 17, 2023

Cancer Trial in St. Gallen (Rogaratinib (BAY1163877), Combination drug)

Completed
  • Cancer
  • Rogaratinib (BAY1163877)
  • Combination drug
  • St. Gallen, Sankt Gallen, Switzerland
    Kantonsspital St. Gallen
Mar 20, 2022

Polycystic Kidney Disease, Adult Trial in Bethlehem (Lixivaptan)

Active, not recruiting
  • Polycystic Kidney Disease, Adult
  • Bethlehem, Pennsylvania
    Northeast Clinical Research Center, LLC
Jun 7, 2022

Acute Lymphoblastic Leukemia Trial in Russian Federation (Lyophilized S95014)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Lyophilized S95014
  • Chelyabinsk, Russian Federation
  • +5 more
Apr 25, 2022

MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • (no location specified)
Aug 5, 2022

Endogenous Cushing Syndrome Trial in Edmonton, Halifax, Sherbrooke (Intervention/Treatment)

Active, not recruiting
  • Endogenous Cushing Syndrome
  • Edmonton, Alberta, Canada
  • +2 more
Nov 9, 2023

Tumors Trial in Japan (Everolimus)

Completed
  • Neoplasms
  • Matsuyama, Ehime, Japan
  • +3 more
Apr 17, 2020

NSCLC, Urothelial Carcinoma Trial in Worldwide (Durvalumab)

Enrolling by invitation
  • Non-Small Cell Lung Cancer
  • Urothelial Carcinoma
  • Newmarket, Ontario, Canada
  • +26 more
Aug 2, 2022

Bronchiectasis Trial (BI 1291583, Placebo matching BI 1291583)

Not yet recruiting
  • Bronchiectasis
  • BI 1291583
  • Placebo matching BI 1291583
  • (no location specified)
Apr 26, 2023

Dental Prosthesis Failure, Frail Elderly Syndrome Trial in Santiago (Procedure: prosthetic functioning, Conventional dental

Recruiting
  • Dental Prosthesis Failure
  • Frail Elderly Syndrome
  • Procedure: prosthetic functioning
  • Conventional dental prosthesis
  • Santiago, Chile
    Hospital Salvador
Apr 5, 2023

Autoimmunity, Inflammation Trial in Worldwide (Secukinumab s.c. injection)

Recruiting
  • Autoimmunity, Inflammation
  • Secukinumab s.c. injection
  • Fullerton, California
  • +93 more
Jul 14, 2022

Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Long-term Follow-up
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)

Not yet recruiting
  • HIV Infections
    • (no location specified)
    Jan 9, 2023

    Lip Augmentation Trial in United States (PN40082)

    Terminated
    • Lip Augmentation
    • PN40082
    • Encinitas, California
    • +4 more
    Jul 28, 2021

    Spine Injuries and Disorders Trial (PO2 osteopathic protocol)

    Not yet recruiting
    • Spine Injuries and Disorders
    • PO2 osteopathic protocol
    • (no location specified)
    Oct 6, 2022

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

    Recruiting
    • Chronic Myelogenous Leukemia
    • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    • Asciminib single agent
    • +5 more
    • Ann Arbor, Michigan
    • +49 more
    Jan 26, 2023

    Removable Dental Prosthesis, Dental Restoration, Elderly Trial in Santiago (prosthetic refunctioning, conventional prosthetic

    Active, not recruiting
    • Removable Dental Prosthesis
    • +3 more
    • prosthetic refunctioning
    • conventional prosthetic treatment
    • Santiago, Chile
      Hospital Salvador
    Oct 24, 2022

    Ovarian Stimulation Trial in Shibin Al Kawm (Letrozole 2.5mg tablet)

    Recruiting
    • Ovarian Stimulation
    • Letrozole 2.5mg tablet
    • Shibīn Al Kawm, Menoufia, Egypt
      Menoufia University hospital
    Dec 8, 2021

    HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

    Recruiting
    • HER2-positive Metastatic Breast Cancer
    • Aurora, Colorado
    • +2 more
    Dec 29, 2022